Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


Cavion
600 East Water Street, Suite E
Charlottesville, VA 22902
Phone: 434-200-8442
http://cavionpharma.com/

Cavion, Inc. is a privately held clinical stage biotechnology company creating therapies modulating the T-type calcium channel (Cav3) for the treatment of neurological and oncologic diseases. Cavion is co-sponsoring a Phase 1 trial of mibefradil combined with hypofractionated radiation therapy for the treatment of recurrent glioblastoma multiforme with the Yale University Comprehensive Cancer Center.

Key Contact
NameTitleE-Mail
Andrew KrouseCEOkrouse@cavionpharma.com


Funding Events
DateAmountTypeInvestors
01/06/17$26,100,000Series A Enso Ventures
Lilly Ventures
Novartis Venture Funds
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.